Callon Nichols | Director of IR |
Ron Nixon | Executive Chairman |
Zachary Fleming | CEO |
Michael McNeil | CFO |
Ross Osborn | Cantor Fitzgerald |
Ian Cassel | IFCM |
Good morning, ladies and gentlemen, and welcome to the Sanara MedTech Inc.
Second Quarter 2022 Earnings and Business Update. At this time, all participants have been placed on a listen-only mode and the floor will be opened for questions and comments after the presentation. It is now my pleasure to turn the floor over to your host, Mr. Callon Nichols, Investor Relations.